Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants
Clinical trial NCT05665647 · COMPLETED
Trial details
- NCT number
- NCT05665647
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2023-01-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.